CTMX Stock Analysis: Buy, Sell, or Hold?
CTMX - CytomX Therapeutics, Inc.
$5.86
0.17 (2.99%)
▲
5d:
+9.74%
30d:
+37.56%
90d:
+75.98%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
30d
Get Alerted When CTMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CTMX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CTMX is 8.3% above fair value ($5.41). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CTMX is 8.3% above fair value ($5.41). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: CTMX is currently trading at $5.86, which is considered extended relative to its 30-day fair value range of $4.07 to $5.41.
Technical Outlook: Technically, CTMX is in a strong uptrend. Immediate support is located at $4.25, while resistance sits at $6.15.
Market Sentiment: CTMX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+49.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CTMX is in a strong uptrend. Immediate support is located at $4.25, while resistance sits at $6.15.
Market Sentiment: CTMX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+49.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$4.07 -
$5.41
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+8.3% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 49.4% below Wall St target ($8.50)
Fair Price Analysis
30-Day Fair Range
$4.07 -
$5.41
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$4.25
Resistance Level
$6.15
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-15.59
Wall Street Target
$8.50
(+49.4%)
Revenue Growth (YoY)
-82.2%
Earnings Growth (YoY)
60.6%
Profit Margin
24.7%
Last updated: February 02, 2026 10:17 AM ET
Data refreshes hourly during market hours. Next update: 11:17 AM
Data refreshes hourly during market hours. Next update: 11:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTMX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$277 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
